论文部分内容阅读
鉴于在急性ST段抬高型心肌梗死(STEMI)患者尽管经有效治疗后死亡风险仍较高,因此有效预测其死亡风险高低尤显重要。既往公认选用TIMI危险积分大小能有效用于预测STEMI后死亡风险高低,然而睌近发现采用N-端前B型利钠肽(NTproBNP)水平高低亦可有效预测STEMI后死亡风险,但两者间何
Given the high risk of death after effective treatment in patients with acute ST-elevation myocardial infarction (STEMI), it is important to effectively predict the risk of death. However, it has been found that the use of NT-ProBNP level can effectively predict the risk of post-STEMI death. However, between the two what